Exagen Inc. to Participate in Fourth Quarter Investor Conferences CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following...

Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...

Conduent to Attend TD Cowen’s 51st Annual Technology, Media and Telecom Conference FLORHAM PARK, N.J., May 24, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today announced that it is scheduled to...